The Shift in Global Drug Development

About this episode

The episode discusses China's rise in global clinical trial output and the implications for US biomedical innovation.

Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the regulatory reforms that accelerated China’s progress, the surge in novel drug development, and what the US would need to change to stay competitive in biomedical innovation.

People in this episode

Hosts: Theo Jaffee, Gabriel Dickinson

Guest: Cremieux

Topics covered

• global drug development
• clinical trials
• biomedical innovation
• regulatory reforms
• China
• US competitiveness

Keywords

• drug development
• clinical trials
• China
• biomedical innovation
• regulatory reforms
• US competitiveness

Mentioned in this episode

Places: China, US

More episodes of The a16z Show

• Samo Burja on Growth, Energy, and AI · June 12, 2026 · 28 min
• Designing the Physical World with AI · June 11, 2026 · 50 min
• Tyler Cowen & Alex Tabarrok on AI, Jobs, and Economic Growth · June 9, 2026 · 59 min
• AI Eats the World? A Reality Check with Benedict Evans · June 8, 2026 · 1h 1m
• Building Search for AI Agents with Exa CEO Will Bryk · June 6, 2026 · 50 min
• AI Agents and the Fight for Customer Data · June 5, 2026 · 51 min